Zanoprima Lifesciences is a research-driven life science company dedicated to scientific innovation and finding solutions for healthier alternatives to tobacco. With deep roots in pharmaceutical research and nicotine innovation, our founders were motivated by the need to address the high rates of oral cancer in India. We have developed cost-effective nicotine replacement therapy (NRT) products, including chewing gum and lozenges, to help individuals transition away from smoking.

Our purpose at Zanoprima is to contribute to a cigarette-free world, eliminating the harmful particle most associated with poor health and death globally. We are committed to creating superior and sustainable alternatives to traditional cigarettes and harnessing the potential of synthetic nicotine and medicinal plants to treat major human ailments. Our flagship product is high purity synthetic (S)-Nicotine (SyNic), which offers a reliable and traceable supply of nicotine with consistent quality.

Unlike plant-derived nicotine, SyNic is free from impurities, contaminants, and related tobacco alkaloids. Our innovative processes are designed to have minimal waste, low energy consumption, and a minimal environmental impact, aligning with our goal of creating a healthier planet. By choosing Zanoprima, you can enjoy the benefits of clean chemistry and sustainable production.

We are dedicated to reducing the harmful effects of smoking and unclean nicotine products and invite you to join us in our mission for responsible nicotine manufacturing and a clean nicotine delivery world. Contact us at info@zanoprima. com to learn more about our products and how we can support you